| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | Chief Financial Officer
1 company
Eugene M Johnston is CFO at MGRX. Eugene M Johnston's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $48K at current prices.
Our model assigns Eugene M Johnston a middling insider score of 65/100, based on 3 past trades. On a 3-month view, all 3 of the rated trades came out ahead, averaging +67.3% over three months.
The MGRX filings lean toward selling, a net 18,333 shares.
Eugene M Johnston has 7 Form 4 filings on record from October 2023 to July 2026, all as CFO at Mangoceuticals (MGRX), 2023–2026.
The 7 reported transactions were 4 stock awards and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $21K.
The largest open-market sale was 10,000 shares of MGRX at an average $1.13 on December 5, 2025, about $11K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.